930783-25-8 Usage
Uses
Used in Pharmaceutical Industry:
(S)-hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one is used as a therapeutic agent for treating erectile dysfunction and symptoms of benign prostatic hyperplasia. Its application is based on its ability to enhance blood flow to the penis during sexual stimulation, leading to an erection. This makes it a valuable treatment option for men experiencing these conditions.
Used in Research and Development:
In addition to its clinical applications, (S)-hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one may also be used in research and development for studying the mechanisms of PDE5 inhibition and its potential applications in other medical conditions. This could lead to the discovery of new therapeutic approaches and the development of novel drugs with similar or improved properties.
Used in Formulation Development:
Tadalafil's versatility in terms of dosage and administration allows for its use in the development of various formulations, such as oral tablets, to cater to the needs of different patients. This flexibility is essential in ensuring that individuals can access and adhere to their prescribed treatment regimen, ultimately improving their quality of life and overall health outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 930783-25-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,7,8 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 930783-25:
(8*9)+(7*3)+(6*0)+(5*7)+(4*8)+(3*3)+(2*2)+(1*5)=178
178 % 10 = 8
So 930783-25-8 is a valid CAS Registry Number.
930783-25-8Relevant academic research and scientific papers
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
-
, (2018/10/25)
Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula (I), or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
NOVEL AZETIDINE COMPOUNDS USEFUL IN THE TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERS, IBS AND FUNCTIONAL DYSPEPSIA
-
Page/Page column 45, (2008/06/13)
The present invention relates to new azetidine compounds, to pharmaceutical compositions cotaining them and the use of said compounds in in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia. The compounds are neurokinin
